Stockscreener 앱 받기
0.00
100.00%
-0.0003
Lipella Pharmaceuticals Inc 주식(LIPO)의 최신 뉴스
Lipella Pharmaceuticals Inc. Revenue Breakdown – OTC:LIPO - TradingView
Lipella Pharmaceuticals Says Bankruptcy Court Approves Sale And Asset Purchase Agreement On June 4 - TradingView
Price to book forward of Lipella Pharmaceuticals Inc. – OTC:LIPO - TradingView
Enterprise value to EBIT forward of Lipella Pharmaceuticals Inc. – OTC:LIPO - TradingView
Price to sales forward of Lipella Pharmaceuticals Inc. – OTC:LIPO - TradingView
Enterprise value to EBITDA forward of Lipella Pharmaceuticals Inc. – OTC:LIPO - TradingView
Lipella Pharmaceuticals Inc (LIPO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Lipella Pharmaceuticals Inc. (LIPO) Stock Price | Live Quotes & Charts | PINL - StocksToTrade
Lipella Pharmaceuticals Inc (LIPO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Lipella Pharmaceuticals Inc (LIPO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Lipella Pharmaceuticals Inc (LIPO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lipella Pharmaceuticals Inc (LIPO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Lipella Pharmaceuticals Inc (LIPO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Lipella Pharmaceuticals Inc (LIPO) Institutional Confidence - TradingKey
Lipella Pharmaceuticals Inc (LIPO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Lipella Pharmaceuticals Inc (LIPO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Lipella Pharmaceuticals Inc. (LIPO) Eps Diluted (TTM) - Zacks Investment Research
TradingKey - TradingKey
Market Wrap: Is Lipella Pharmaceuticals Inc stock good for income investorsForecast Cut & Smart Investment Allocation Insights - baoquankhu1.vn
Hedge Fund Moves: Whats the beta of Lipella Pharmaceuticals Inc stockWeekly Investment Report & Risk Controlled Swing Alerts - baoquankhu1.vn
Options Flow: Can Lipella Pharmaceuticals Inc deliver consistent EPS growth2026 Review & Real-Time Buy Signal Notifications - baoquankhu1.vn
Insider Trends: Is Lipella Pharmaceuticals Inc forming a breakout pattern2026 Momentum & Real-Time Volume Spike Alerts - baoquankhu1.vn
1080highp-h264Dailyhunt - Dailyhunt
Lipella Pharmaceuticals files for bankruptcy protection four years after going public - WPXI
Stock List: Research Stocks from Around the World - GuruFocus
Pittsburgh biotech company Lipella Pharmaceuticals files for bankruptcy protection - TribLIVE.com
Future Perspectives: Key Trends Shaping the Lichen Planus Market Until 2030 - openPR.com
Sell Signal: Is Lipella Pharmaceuticals Inc forming a breakout pattern2026 Bull vs Bear & Real-Time Price Movement Reports - baoquankhu1.vn
Lipella Pharmaceuticals Begins Chapter 11 Bankruptcy Restructuring Process - TipRanks
Biotech Company Files for Chapter 11 Bankruptcy, Plans Asset Sale - WhatNow
Lipella Pharmaceuticals Files for Chapter 11 Bankruptcy - National Today
Entry Recap: Will ELAB benefit from rising consumer demandAnalyst Upgrade & Entry Point Confirmation Alerts - baoquankhu1.vn
Tenaris Files its 2025 Annual Report and its Annual Report on Form 20-F - The Manila Times
US Senators send letter to SEC, requesting explanation for former enforcement chief's brief tenure and reversal of decisions on crypto cases - Bitget
Legal risks combined with AI's high costs cause Meta's market value to evaporate by $280 billions, raising concerns about tobacco industry-style risks - Bitget
Lipella Pharmaceuticals Inc plans to file customary "first day" relief motions with the court. - Bitget
Tims China Announces Q4 and Full Year 2025 Results Conference Call - The Manila Times
Lipella Pharmaceuticals Inc. Files Voluntary Petitions for Relief Under Chapter 11 - The Manila Times
Dropship China Pro Expands US Fulfillment Warehouse Operations to Meet Growing Demand for Faster E-commerce Delivery - The Manila Times
Lipella Pharmaceuticals Inc. Files Voluntary Petitions For Relief Under Chapter 11 - TradingView — Track All Markets
Lipella Pharmaceuticals files for Chapter 11 ba... - Pluang
Pelvic Cancer Induced Hemorrhagic Cystitis Market Poised - GlobeNewswire
Lipella Pharmaceuticals Inc.: Fundamental Analysis and Financial Ratings | | US53630L2097 - marketscreener.com
Patterns Watch: Whats the beta of Lipella Pharmaceuticals Inc stockRecession Risk & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Decliners Report: Can Lipella Pharmaceuticals Inc maintain its current growth rate2026 Intraday Action & Trade Opportunity Analysis Reports - baoquankhu1.vn
Price Action: Can Lipella Pharmaceuticals Inc grow without external fundingWeekly Trade Report & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Chipmakers Recap: What is the next catalyst for Lipella Pharmaceuticals IncJuly 2025 Opening Moves & Target Return Focused Stock Picks - baoquankhu1.vn
Dip Buying: How does Lipella Pharmaceuticals Inc score in quality rankingsPortfolio Update Summary & Stock Timing and Entry Methods - baoquankhu1.vn
LIPO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Short Covering: Is Lipella Pharmaceuticals Inc a strong candidate for buy and holdJuly 2025 Selloffs & Weekly Market Pulse Updates - baoquankhu1.vn
Will Lipella Pharmaceuticals Inc. stock hit new highs in YEARJuly 2025 Gainers & Stock Timing and Entry Methods - mfd.ru
Investment Review: What is the next catalyst for Lipella Pharmaceuticals Inc2025 Analyst Calls & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Interstitial Cystitis Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | UCB Pharma, Lipella Pharma, Allergan, PureTech Health, Imbrium - Barchart.com
Lipella Pharmaceuticals (LIPO) director Lori A. Birder steps down from board - Stock Titan
Fierce Biotech Layoff Tracker 2026: Lipella, IO shutter; Takeda plots 634 US job cuts - Fierce Biotech
Lipella Pharmaceuticals Announces CMO Retirement - Barchart
How LP-10 Could Transform Treatment for Oral Lichen Planus - Dermatology Times
Delisting of Securities from The Nasdaq Stock Market - Yahoo Finance
Lipella Pharmaceuticals Announces Positive Final Results from Phase 2a Study of LP-10 in Oral Lichen Planus - Yahoo Finance
Life Science Virtual Investor Forum Agenda Announced for September 18th - Investing News Network
Lipella Pharmaceuticals to Present at Zacks SCR Life Sciences Virtual Investor Forum and Report Final Phase 2a Results in Oral Lichen Planus - PR Newswire
ZVSA Stock Price and Chart — OTC:ZVSA - TradingView
LIPO SEC FilingsLipella Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Lipella Pharmaceuticals delisted from Nasdaq, explores relisting options amid ongoing operations - The Business Journals
Lipella Pharmaceuticals Issues Letter from the CEO to Stockholders Following Nasdaq Delisting - Yahoo Finance
Dow Jumps Over 200 Points; FactSet Research Shares Gain After Q3 Results - Benzinga
1.21%
1.07%
자본화:
|
볼륨(24시간):